(Q38303199)

1 September 2017

title

Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein (English)

1 reference

1 September 2017

Vafai A

1

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

1 September 2017

1 reference

1 September 2017

volume

12

1 reference

1 September 2017

issue

14

1 reference

1 September 2017

page(s)

1265-1269

1 reference

The complete DNA sequence of varicella-zoster virus

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

The development of biosynthetic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Recognition of similar epitopes on varicella-zoster virus gpI and gpIV by monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

O-linked glycosylation of retroviral envelope gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Serological reactivity of some monoclonal antibodies to varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Monoclonal antibodies against three major glycoproteins of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

The Children's Vaccine Initiative--will it work?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2894%2980030-4

7 January 2021

10.1016/S0264-410X(94)80030-4

Identifiers

DOI

1 reference

1 September 2017

1 reference